How to contribute
The funding challenge
The COVID-19 pandemic is far from over, with new variants and case surges affecting many countries around the world.
We have seen the power of vaccines to protect vulnerable people, the lifesaving impact of access to oxygen and treatments, the importance of testing to control transmission and inform responses, and the necessity of PPE to protect our health workers.
But these tools are still not available to all communities and all people.
As of the end of 2021, more than 40 countries were yet to achieve 10% vaccine coverage and almost half of the 194 WHO member states missed the 40% vaccine coverage target. The global daily testing target of 1 per 1000 head of population is also not being met, with large disparities between low-income countries and high-income countries. This mix of low testing and low vaccination fuels the spread of new variants.
Financing the ACT-Accelerator is a global health, economic and political imperative. Fully funding the US$ 23.4 billion new ACT-Accelerator Strategic Plan and Budget will play a crucial role in meeting global targets and delivering the tools that are needed by countries.
In addition, there is a need for US$ 24.6 billion for procurement and in-country capacities to deliver vaccines and other tools beyond the work of the ACT-Accelerator to ensure global targets are reached.
We will not be able to control the pandemic if the inequity in access to COVID-19 tools continues. We all have a role to play.